IM Cannabis Logo
CA44969Q2080
A2QQPZ
IMCC

IM Cannabis

Prognoza

Kupuj
  1
Trzymaj
  0
Sprzedaj
  0

Dyskusje w społeczności

Nie ma jeszcze dyskusji o tym aktywie.

Rozpocznij dyskusję

  • IM Cannabis approves 1-for-30 reverse stock split to restore NASDAQ listing compliance

    The board of IM Cannabis has approved a 1-for-30 reverse stock consolidation to become effective August 27 and will keep the ticker symbol IMCC unchanged. Outstanding common shares will be reduced from about 18,117,650 to approximately 603,922; fractional shares will be rounded up or cancelled, and the exercise and conversion prices of convertible securities will be adjusted proportionally. The measure aims to raise the per-share price to meet NASDAQ’s $1.00 minimum; IM Cannabis has until October 6, 2026 to regain compliance within the 180‑day cure period, but there is no guarantee of success. » Więcej na de.investing.com


  • IM Cannabis sells European business to Slil.com Holding controlled by the CEO

    IM Cannabis has agreed to sell all shares of I.M.C. Holdings to Slil.com Holding, with the Israeli medical-cannabis business being spun off before closing and remaining with IM Cannabis. The consideration includes CAD 3 million in prepaid amounts already made and the assumption of liabilities expected to be up to CAD 9.4 million, with no issuance of securities. The transaction is a related-party transaction because Slil is economically owned by Oren Shuster, the CEO; the board has formed a special committee and engaged Beta Finance for a fairness opinion. Closing conditions apply and the outside closing date is September 30, 2026. » Więcej na de.investing.com


  • IM Cannabis closes $250,000 convertible note with 8% interest

    IM Cannabis completed a private placement of a $250,000 convertible note with an initial issue discount of 10%; the note bears interest at 8% per annum, rising to 14% upon default. Repayment will be made solely in common shares at the lower of $0.122 per share or 90% of the lowest daily VWAP over the 20 consecutive trading days prior to conversion, with a floor price of $0.02436 and a participation cap of 4.99%. In addition, warrants for up to 2,052,545 common shares at C$0.17 were issued; net proceeds will be used for general corporate purposes and the securities are subject to a four-month hold period and planned registration filings with the SEC. » Więcej na de.investing.com


  • Alon Dayan resigns from IM Cannabis supervisory board

    IM Cannabis announces the resignation of supervisory board member Alon Dayan for personal reasons and does not name a successor. The company provided no further details on the background. IM Cannabis operates distribution and pharmacies for medical cannabis in Israel and Germany and is exploring expansion opportunities into technology-oriented areas. » Więcej na de.investing.com


  • IM Cannabis secures $550,000 via two convertible notes

    IM Cannabis closed an additional $300,000 convertible note, bringing total proceeds from recent financing rounds to $550,000. Both notes carry a 10% issuance discount, pay 8% interest (14% on default) and are to be settled in common shares upon conversion rather than in cash. The conversion prices, accompanying warrants and a 4.99% ownership cap reflect dilution and investor concerns; the stock trades near year-to-date losses and a 52-week low, with a market capitalization of about $1.62 million. » Więcej na de.investing.com

Dane finansowe

W ostatnim kwartale IM Cannabis osiągnęła przychody w wysokości 1,01 mln € i zysk netto w wysokości -4,34 mln €

(EUR) wrzesień 2026
YoY
Przychody 1,01 mln 88,04%
Zysk brutto -21,5 tys. 101,29%
Zysk netto -4,34 mln 94,29%
EBITDA -1,58 mln 29,12%

Dane fundamentalne

Wskaźnik Wartość
Kapitalizacja rynkowa
750,57 tys. €
Liczba akcji
1,65 mln
Maksimum/minimum z 52 tygodni
56,87 € - 0,33 €
Dywidendy Nie
Beta
2,21
C/Z (PE Ratio)
-0,02
PEG (PEG Ratio)
0,00
C/WK (PB Ratio)
-0,17
C/S (PS Ratio)
0,04

Profil spółki

IM Cannabis Corp. zajmuje się hodowlą, uprawą i dostawą medycznych produktów konopnych w Izraelu, Niemczech i Kanadzie. Oferuje kwiaty konopi oraz ekstrakty z konopi o określonych odmianach pod marką IMC, a także suszone kwiaty, pre-rolle i prasowany haszysz pod markami WAGNERS i Highland Grow. Firma obsługuje pacjentów medycznych oraz dorosłych konsumentów rekreacyjnych. Siedziba IM Cannabis Corp. znajduje się w Tel Awiwie-Jafie w Izraelu.

Nazwa
IM Cannabis
CEO
Oren Shuster
Siedziba Vancouver, bc
Izrael
Strona internetowa
Sektor
Dobra podstawowe
Branża
Produkty higieny osobistej
Debiut giełdowy
20.05.2020
Pracownicy 44

Symbole giełdowe

Giełda Symbol
NASDAQ
IMCC
🍪

Parqet  używa plików cookie. Dowiedz się więcej